Sumitomo Pharma America, Inc

Sumitomo Pharma America, Inc. is a leading biopharmaceutical company dedicated to improving the health and well-being of patients through innovative therapies. Established as a subsidiary of Sumitomo Pharma Co., Ltd., the company focuses on developing and commercialising novel treatments in various therapeutic areas, including psychiatry, neurology, and oncology.

With a commitment to research and development, Sumitomo Pharma America invests significantly in clinical trials and collaborations with academic institutions and other pharmaceutical companies. This approach enables the company to stay at the forefront of medical advancements and address unmet medical needs.

The company’s vision is to create a healthier society by providing effective and safe medications that enhance the quality of life for patients. Sumitomo Pharma America strives to achieve this by fostering a culture of innovation, integrity, and collaboration among its employees.

• Core Values: Innovation, Integrity, Collaboration
• Therapeutic Areas: Psychiatry, Neurology, Oncology
• Commitment: Patient-Centric Approach

Headquartered in the United States, Sumitomo Pharma America operates with a global perspective, leveraging its parent company’s extensive resources and expertise. The company is also dedicated to corporate social responsibility, engaging in initiatives that support community health and education.

Through its ongoing efforts, Sumitomo Pharma America aims to be a trusted partner in healthcare, delivering solutions that make a meaningful difference in the lives of patients and their families.